Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07185308 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Postbiotics Ameliorate Cachexia in Patients With Non-small-cell Lung Cancer

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 0 to 1v2 Show 4 more changesShow less
    • Interventions: Placebo, 2.5 g per dose, three times per day (Dietary Supplement), Postbiotics, 2.5 g, per dose, three times per day (Dietary Supplement) to Placebo, 2.5 g per dose, three times per day (Dietary Supplement), Postbiotics, 2.5 g per dose, three times per day (Dietary Supplement)
    • Eligibility criteria expanded, about 20 words
    • Collaborators expanded, about 43 words
    • Study title shortened, about 1 word
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the efficacy of the oral postbiotic preparation JK-5G in improving body weight among patients with non-small-cell lung cancer (NSCLC)-related cachexia. By means of a randomized controlled trial, we will compare the between-group difference in body-weight changes between the JK-5G and placebo arms to clarify its nutritional therapeutic benefit.
Trial Details
NCT Number NCT07185308
Lead Sponsor Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Collaborators: First Affiliated Hospital of Wenzhou Medical University, The First Hospital of Jilin University, Fujian Cancer Hospital, Zhongnan Hospital, National Cancer Center, China, Affiliated Hospital of Jiangnan University, Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Zhengzhou University, Shanghai Changzheng Hospital, Zhengzhou University
Conditions
(from sponsor)		 Cachexia; Cancer
Related terms Cachexia, Carcinoma, Non-Small-Cell Lung, Neoplasms
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov